219 related articles for article (PubMed ID: 33869279)
1. Radiomics of Tumor Heterogeneity in Longitudinal Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Predicting Response to Neoadjuvant Chemotherapy in Breast Cancer.
Fan M; Chen H; You C; Liu L; Gu Y; Peng W; Gao X; Li L
Front Mol Biosci; 2021; 8():622219. PubMed ID: 33869279
[TBL] [Abstract][Full Text] [Related]
2. Multiparametric MRI radiomics fusion for predicting the response and shrinkage pattern to neoadjuvant chemotherapy in breast cancer.
Fan M; Wu X; Yu J; Liu Y; Wang K; Xue T; Zeng T; Chen S; Li L
Front Oncol; 2023; 13():1057841. PubMed ID: 37207135
[TBL] [Abstract][Full Text] [Related]
3. Early Prediction of Breast Cancer Therapy Response using Multiresolution Fractal Analysis of DCE-MRI Parametric Maps.
Machireddy A; Thibault G; Tudorica A; Afzal A; Mishal M; Kemmer K; Naik A; Troxell M; Goranson E; Oh K; Roy N; Jafarian N; Holtorf M; Huang W; Song X
Tomography; 2019 Mar; 5(1):90-98. PubMed ID: 30854446
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Tumor Shrinkage Pattern to Neoadjuvant Chemotherapy Using a Multiparametric MRI-Based Machine Learning Model in Patients With Breast Cancer.
Huang Y; Chen W; Zhang X; He S; Shao N; Shi H; Lin Z; Wu X; Li T; Lin H; Lin Y
Front Bioeng Biotechnol; 2021; 9():662749. PubMed ID: 34295877
[No Abstract] [Full Text] [Related]
5. Radiomics Based on Dynamic Contrast-Enhanced MRI to Early Predict Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Therapy.
Zeng Q; Ke M; Zhong L; Zhou Y; Zhu X; He C; Liu L
Acad Radiol; 2023 Aug; 30(8):1638-1647. PubMed ID: 36564256
[TBL] [Abstract][Full Text] [Related]
6. Radiomics of MRI for the Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Single Referral Centre Analysis.
Pesapane F; Rotili A; Botta F; Raimondi S; Bianchini L; Corso F; Ferrari F; Penco S; Nicosia L; Bozzini A; Pizzamiglio M; Origgi D; Cremonesi M; Cassano E
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503081
[TBL] [Abstract][Full Text] [Related]
7. Deep learning radiomic analysis of DCE-MRI combined with clinical characteristics predicts pathological complete response to neoadjuvant chemotherapy in breast cancer.
Li Y; Fan Y; Xu D; Li Y; Zhong Z; Pan H; Huang B; Xie X; Yang Y; Liu B
Front Oncol; 2022; 12():1041142. PubMed ID: 36686755
[TBL] [Abstract][Full Text] [Related]
8. Nomogram based on quantitative dynamic contrast-enhanced magnetic resonance imaging, apparent diffusion coefficient, and clinicopathological features for early prediction of pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy.
He M; Su J; Ruan H; Song Y; Ma M; Xue F
Quant Imaging Med Surg; 2023 Jul; 13(7):4089-4102. PubMed ID: 37456283
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
10. Response to neoadjuvant treatment of invasive ductal breast carcinomas including outcome evaluation: MRI analysis by an automatic CAD system in comparison to visual evaluation.
Böttcher J; Renz DM; Zahm DM; Pfeil A; Fallenberg EM; Streitparth F; Maurer MH; Hamm B; Engelken FJ
Acta Oncol; 2014 Jun; 53(6):759-68. PubMed ID: 24299492
[TBL] [Abstract][Full Text] [Related]
11. Machine learning classification of texture features of MRI breast tumor and peri-tumor of combined pre- and early treatment predicts pathologic complete response.
Hussain L; Huang P; Nguyen T; Lone KJ; Ali A; Khan MS; Li H; Suh DY; Duong TQ
Biomed Eng Online; 2021 Jun; 20(1):63. PubMed ID: 34183038
[TBL] [Abstract][Full Text] [Related]
12. Radiomic analysis of DCE-MRI for prediction of response to neoadjuvant chemotherapy in breast cancer patients.
Fan M; Wu G; Cheng H; Zhang J; Shao G; Li L
Eur J Radiol; 2017 Sep; 94():140-147. PubMed ID: 28712700
[TBL] [Abstract][Full Text] [Related]
13. Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy.
Wu J; Gong G; Cui Y; Li R
J Magn Reson Imaging; 2016 Nov; 44(5):1107-1115. PubMed ID: 27080586
[TBL] [Abstract][Full Text] [Related]
14. Delta-Radiomics Based on Dynamic Contrast-Enhanced MRI Predicts Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Guo L; Du S; Gao S; Zhao R; Huang G; Jin F; Teng Y; Zhang L
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884576
[TBL] [Abstract][Full Text] [Related]
15. DCE-MRI Texture Features for Early Prediction of Breast Cancer Therapy Response.
Thibault G; Tudorica A; Afzal A; Chui SY; Naik A; Troxell ML; Kemmer KA; Oh KY; Roy N; Jafarian N; Holtorf ML; Huang W; Song X
Tomography; 2017 Mar; 3(1):23-32. PubMed ID: 28691102
[TBL] [Abstract][Full Text] [Related]
16. Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer.
Li ZY; Wang XD; Li M; Liu XJ; Ye Z; Song B; Yuan F; Yuan Y; Xia CC; Zhang X; Li Q
World J Gastroenterol; 2020 May; 26(19):2388-2402. PubMed ID: 32476800
[TBL] [Abstract][Full Text] [Related]
17. Quantitative DCE-MRI prediction of breast cancer recurrence following neoadjuvant chemotherapy: a preliminary study.
Thawani R; Gao L; Mohinani A; Tudorica A; Li X; Mitri Z; Huang W
BMC Med Imaging; 2022 Oct; 22(1):182. PubMed ID: 36266631
[TBL] [Abstract][Full Text] [Related]
18. Combining Dynamic Contrast-Enhanced Magnetic Resonance Imaging and Apparent Diffusion Coefficient Maps for a Radiomics Nomogram to Predict Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients.
Chen X; Chen X; Yang J; Li Y; Fan W; Yang Z
J Comput Assist Tomogr; 2020; 44(2):275-283. PubMed ID: 32004189
[TBL] [Abstract][Full Text] [Related]
19. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
20. Early prediction of treatment response to neoadjuvant chemotherapy based on longitudinal ultrasound images of HER2-positive breast cancer patients by Siamese multi-task network: A multicentre, retrospective cohort study.
Liu Y; Wang Y; Wang Y; Xie Y; Cui Y; Feng S; Yao M; Qiu B; Shen W; Chen D; Du G; Chen X; Liu Z; Li Z; Yang X; Liang C; Wu L
EClinicalMedicine; 2022 Oct; 52():101562. PubMed ID: 35928032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
